Neglected Tropical Diseases Diagnosis Market - 2024-2031

September 2023 | 63 pages | ID: N42F1DADF4F0EN
DataM Intelligence

Abstracts

Neglected Tropical Diseases Diagnosis Marketis is growing with a CAGR of 4.30% during the forecast period 2026-2035.

The Neglected Tropical Diseases Diagnosis Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Neglected Tropical Diseases Diagnosis Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Disease

• Dengue*
• Chikungunya
• Rabies
• Lymphatic Filariasis
• Buruli Ulcer
• Leprosy
• Others

By Diagnostic Method

• Conventional Method*
• Molecular Method

By Service Type

• Centralized Service*
• Point-of-care Testing

By End user

• Hospitals*
• Clinical Laboratories
• Others

Regional Analysis for Neglected Tropical Diseases Diagnosis Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Neglected Tropical Diseases Diagnosis Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet by Disease
3.2. Market Snippet by Diagnostic Method
3.3. Market Snippet by Service Type
3.4. Market Snippet by End User
3.5. Market Snippet by Region

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Innovative technologies to diagnose Neglected Tropical Diseases are expected to drive market growth.
  4.1.2. Restraints:
    4.1.2.1. The high costs of diagnostic tests and kits are expected to hamper in the forecast period.
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Supply Chain Analysis
5.2. Pricing Analysis
5.3. Unmet Needs

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY DISEASE

7.1. Introduction
  7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
  7.1.2. Market Attractiveness Index, By Disease Segment
7.2. Dengue*
  7.2.1. Introduction
  7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Chikungunya
7.4. Rabies
7.5. Lymphatic Filariasis
7.6. Buruli Ulcer
7.7. Leprosy
7.8. Others

8. BY DIAGNOSTIC METHOD

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
  8.1.2. Market Attractiveness Index, By Diagnostic Method Segment
8.2. Conventional Method*
  8.2.1. Introduction
  8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Molecular Method

9. BY SERVICE TYPE

9.1. Introduction
  9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
  9.1.2. Market Attractiveness Index, By Service Type Segment
9.2. Centralized Service*
  9.2.1. Introduction
  9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Point-of-care Testing

10. BY END USER

10.1. Introduction
  10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  10.1.2. Market Attractiveness Index, By End user Segment
10.2. Hospitals*
  10.2.1. Introduction
  10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Clinical Laboratories
10.4. Others

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
  11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
  11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
  11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.2.7.1. U.S.
    11.2.7.2. Canada
    11.2.7.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
  11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
  11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
  11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.3.7.1. Germany
    11.3.7.2. U.K.
    11.3.7.3. France
    11.3.7.4. Italy
    11.3.7.5. Spain
    11.3.7.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
  11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
  11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
  11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.4.7.1. Brazil
    11.4.7.2. Argentina
    11.4.7.3. Rest of South America
11.5. Asia Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
  11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
  11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
  11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.5.7.1. China
    11.5.7.2. India
    11.5.7.3. Japan
    11.5.7.4. Australia
    11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
  11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
  11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
  11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. COMPETITIVE LANDSCAPE

12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
12.4. List of Key Companies to Watch

13. COMPANY PROFILES

13.1. Abbott Laboratories*
  13.1.1. Company Overview
  13.1.2. Product Portfolio and Description
  13.1.3. Key Highlights
  13.1.4. Financial Overview
13.2. Bio-Rad Laboratories, Inc.
13.3. Coris BioConcept
13.4. Genome Diagnostics Pvt. Ltd
13.5. InBios International, Inc.
13.6. Oscar Medicare Pvt Ltd.
13.7. Thermo Fisher Scientific, Inc.
13.8. ZeptoMetrix, LLC
13.9. Premier Medical Corporation Ltd.
13.10. EUROIMMUN Medizinische Labordiagnostika AG(*LIST NOT EXHAUSTIVE)

14. DATAM INTELLIGENCE

14.1. Appendix
14.2. About Us and Applications
14.3. Contact Us